Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription


5 Ann Surg
3 BMC Cancer
1 BMC Ophthalmol
3 Br J Oral Maxillofac Surg
1 Cancer Res
4 Dis Esophagus
3 Head Neck
2 Histopathology
3 Int J Radiat Oncol Biol Phys
1 J Laryngol Otol
5 Laryngoscope
1 Oral Oncol
2 Radiol Imaging Cancer
4 Radiother Oncol
13 Thyroid

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg

  1. CARBONI F, Valle M
    Comment on: "Gastrectomy Versus Esophagectomy For Gastroesophageal Junction Tumors: Short-And Long-term Outcomes From the Dutch Upper GI Cancer Audit".
    Ann Surg. 2022;276:e1121.

  2. GOTTLIEB-VEDI E, Kauppila JH, Mattsson F, Lindblad M, et al
    Long-term Survival in Esophageal Cancer After Minimally Invasive Esophagectomy Compared to Open Esophagectomy.
    Ann Surg. 2022;276:e744-e748.
    PubMed         Abstract available

  3. KALFF MC, Fransen LFC, de Groot EM, Gisbertz SS, et al
    Long-term Survival After Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Propensity-score Matched Analysis.
    Ann Surg. 2022;276:e749-e757.
    PubMed         Abstract available

  4. SIHAG S, Nobel T, Hsu M, De La Torre S, et al
    Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?
    Ann Surg. 2022;276:1017-1022.
    PubMed         Abstract available

  5. JEZERSKYTE E, Mertens AC, Dieren SV, Eshuis WJ, et al
    Gastrectomy Versus Esophagectomy for Gastroesophageal Junction Tumors: Short- and Long-Term Outcomes From the Dutch Upper Gastrointestinal Cancer Audit.
    Ann Surg. 2022;276:e735-e743.
    PubMed         Abstract available

    BMC Cancer

  6. YANG Z, Lin H, Wang Z, Rong L, et al
    The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment.
    BMC Cancer. 2022;22:1180.
    PubMed         Abstract available

  7. SAWICKI CM, Janal MN, Nicholson SJ, Wu AK, et al
    Oral cancer patients experience mechanical and chemical sensitivity at the site of the cancer.
    BMC Cancer. 2022;22:1165.
    PubMed         Abstract available

  8. KAIDA H, Yasuda T, Shiraishi O, Kato H, et al
    The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:1176.
    PubMed         Abstract available

    BMC Ophthalmol

  9. HAN Y, Kong M, Luo Y, Sun B, et al
    Clinicopathological features of patients with wide local excision of eyelid malignant neoplasms: a more than five years retrospective study from China.
    BMC Ophthalmol. 2022;22:436.
    PubMed         Abstract available

    Br J Oral Maxillofac Surg

  10. LIN NC, Hsu JT, Chen MYC, Tsai KY, et al
    Maximum standardised uptake value is prognostic in patients with early-stage squamous cell carcinoma of the tongue.
    Br J Oral Maxillofac Surg. 2022;60:1209-1215.
    PubMed         Abstract available

  11. WICKS C, Zubair F, Ogunbowale A, McMahon J, et al
    The relative propensity for regional metastasis in floor of mouth squamous cell carcinoma versus other oral cavity subsites.
    Br J Oral Maxillofac Surg. 2022;60:1276-1278.
    PubMed         Abstract available

  12. TOFANELLI M, Rigo S, Polesel J, Zanconati F, et al
    Accuracy of fine-needle aspiration and frozen section for the detection of squamous metastasis in cystic masses of the lateral neck.
    Br J Oral Maxillofac Surg. 2022;60:1261-1265.
    PubMed         Abstract available

    Cancer Res

  13. LIU Y, Kramer JR, Sandulache VC, Yu R, et al
    Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort.
    Cancer Res. 2022 Nov 15. pii: 710888. doi: 10.1158/0008-5472.CAN-22-1641.
    PubMed         Abstract available

    Dis Esophagus

  14. JIANG D, Liu XB, Xing WQ, Chen PN, et al
    Survival impact of the number of lymph nodes dissection in patients receiving neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Dis Esophagus. 2022 Nov 17. pii: 6831875. doi: 10.1093.
    PubMed         Abstract available

  15. MUIR D, Antonowicz S, Whiting J, Low D, et al
    Implementation of the Esophagectomy Complication Consensus Group definitions: the benefits of speaking the same language.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available

  16. NISHIMURA K, Miyata K, Fukaya M, Yokoyama Y, et al
    Early volume loss of skeletal muscle after esophagectomy: a risk for late-onset postoperative pneumonia.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available

  17. SZACHNOWICZ S, Duarte AF, Nasi A, da Rocha JRM, et al
    Laparoscopic total fundoplication is superior to medical treatment for reducing the cancer risk in Barrett's esophagus: a long-term analysis.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available

    Head Neck

  18. HU X, Tian T, Zhang X, Sun Q, et al
    Neutrophil-to-lymphocyte and hypopharyngeal cancer prognosis: System review and meta-analysis.
    Head Neck. 2022 Nov 11. doi: 10.1002/hed.27246.
    PubMed         Abstract available

  19. LI W, Liu Q, Xu H, Wang H, et al
    Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Nov 15. doi: 10.1002/hed.27244.
    PubMed         Abstract available

  20. KOTEVSKI DP, Smee RI, Vajdic CM, Field M, et al
    Empirical comparison of routinely collected electronic health record data for head and neck cancer-specific survival in machine-learnt prognostic models.
    Head Neck. 2022 Nov 11. doi: 10.1002/hed.27241.
    PubMed         Abstract available


  21. NUTI S, Zhang Y, Zerrouki N, Roach C, et al
    High interobserver and intraobserver reproducibility among pathologists assessing PD-L1 CPS across multiple indications.
    Histopathology. 2022;81:732-741.
    PubMed         Abstract available

  22. GAO HW, Sun PL
    Pulmonary sialadenoma papilliferum and its mimics: what you need to know.
    Histopathology. 2022;81:715-723.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  23. REYES EG, Tonse R, Chundru S, Kaiser A, et al
    Variable Relative Biological Effectiveness of Proton Therapy Increases PET Visible Mucosal Injury in Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03508.
    PubMed         Abstract available

  24. NAKAJIMA S, Mimura K, Kaneta A, Saito K, et al
    Radiation-induced remodeling of the tumor-microenvironment through tumor cell-intrinsic expression of cGAS-STING in esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03512.
    PubMed         Abstract available

  25. FU S, Li Y, Han Y, Wang H, et al
    Erratum to: Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical T
    Int J Radiat Oncol Biol Phys. 2022;114:1055-1056.

    J Laryngol Otol

  26. HALLIDAY E, George A
    Quantifying the shrinkage of laryngeal laser excisions: a case control study.
    J Laryngol Otol. 2022;136:1265-1270.
    PubMed         Abstract available


  27. CRISTALLI G, Vidiri A, Mercante G, Ferreli F, et al
    Radiological Findings in Laryngeal Anterior Commissure Invasion: CT Scan Highlights.
    Laryngoscope. 2022;132:2427-2433.
    PubMed         Abstract available

  28. GUO R, Jenkins SM, Johnson BJ, Reed K, et al
    Sinonasal Mucosal Melanoma: Role of Tumor Proliferative Indices and Pathological Factors in Survival.
    Laryngoscope. 2022;132:2350-2358.
    PubMed         Abstract available

  29. MANI S, Panda S, Kumar R, Singh CA, et al
    In Reference to Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers.
    Laryngoscope. 2022 Nov 17. doi: 10.1002/lary.30480.

  30. ANDERSON E, Luu M, Ho AS, Zumsteg ZS, et al
    In Response to Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers.
    Laryngoscope. 2022 Nov 17. doi: 10.1002/lary.30481.

  31. HALLER TJ, Van Abel KM, Yin LX, Lohse CM, et al
    Ultrasound Guided Biopsy in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Laryngoscope. 2022;132:2396-2402.
    PubMed         Abstract available

    Oral Oncol

  32. CHAN JYK, Cheung MK, Lan L, Ng C, et al
    Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes.
    Oral Oncol. 2022;135:106245.
    PubMed         Abstract available

    Radiol Imaging Cancer

    Normalized Dynamic Contrast-enhanced Perfusion and Diffusion-weighted MRI Parameters Distinguish Head and Neck Cancer Recurrence from Posttreatment Changes.
    Radiol Imaging Cancer. 2022;4:e229024.

  34. ALVES IS, Feher O, Mattedi R, de Lima Docema MF, et al
    Carcinomatous Encephalitis Secondary to Squamous Cell Carcinoma of the Tongue.
    Radiol Imaging Cancer. 2022;4:e220087.

    Radiother Oncol

  35. WANG G, Huang C, Yang K, Guo R, et al
    Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
    Radiother Oncol. 2022 Nov 11. pii: S0167-8140(22)04548.
    PubMed         Abstract available

  36. YAO JJ, Jin YN, Lin YJ, Zhang WJ, et al
    The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy.
    Radiother Oncol. 2022 Nov 11. pii: S0167-8140(22)04547.
    PubMed         Abstract available

  37. BIN Y, Meng Z, Huang LL, Hu XY, et al
    Prognostic value of the cervical lymph node necrosis ratio in nasopharyngeal carcinoma.
    Radiother Oncol. 2022 Nov 11. pii: S0167-8140(22)04549.
    PubMed         Abstract available

  38. TAKADA A, Ichikawa Y, Nakamura S, Toyomasu Y, et al
    Preliminary results of reduced myocardial blood flow in the subacute phase after radiation therapy for thoracic esophageal cancer: A quantitative analysis with stress dynamic myocardial computed tomography perfusion imaging.
    Radiother Oncol. 2022 Nov 10. pii: S0167-8140(22)04546.


  39. HO AS, Bastien AJ, Sacks W
    Thyroid Cancer Active Surveillance: The Devil You Know Or The Devil You Don't.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2022.0541.
    PubMed         Abstract available

  40. LEE EK, Moon JH, Hwangbo Y, Ryu CH, et al
    Progression of Low-risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) in Korea.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2021.0614.
    PubMed         Abstract available

  41. TUTTLE RM MD, Fagin JA, Minkowitz G, Wong RJ, et al
    Active surveillance of papillary thyroid cancer-frequency and time course of the 6 most common tumor volume kinetic patterns.
    Thyroid. 2022 Sep 30. doi: 10.1089/thy.2022.0325.
    PubMed         Abstract available

  42. GUILMETTE J, Dias-Santagata D, Lennerz JK, Selig MK, et al
    Primary Thyroid Neoplasm with Fetal Morphology Associated with DICER1 Mutations: Expanding the Diagnostic Profile of Thyroblastoma.
    Thyroid. 2022 Sep 30. doi: 10.1089/thy.2022.0060.
    PubMed         Abstract available

  43. HE Q, Cao H, Zhao Y, Chen P, et al
    DPP4 stabilizes integrin alpha4beta1 complex to promote thyroid cancer cell metastasis by activating TGF-beta signaling pathway.
    Thyroid. 2022 Sep 27. doi: 10.1089/thy.2022.0317.
    PubMed         Abstract available

  44. GRANI G, Lamartina L, Montesano T, Giacomelli L, et al
    Prevalence of thyroid nodules and thyroid cancer in individuals with a first-degree family history of non-medullary thyroid cancer: a cross-sectional study based on sonographic screening.
    Thyroid. 2022 Sep 13. doi: 10.1089/thy.2022.0253.
    PubMed         Abstract available

  45. BUI QA, Gunathilake M, Lee J, Lee EK, et al
    Relationship between physical activity levels and thyroid cancer risk: A prospective cohort study in Korea.
    Thyroid. 2022 Sep 7. doi: 10.1089/thy.2022.0250.
    PubMed         Abstract available

  46. SUZUKI S, Suzuki S, Iwadate M, Matsuzuka T, et al
    Possible association between thyroid nodule formation and developmental alterations in the pituitary-thyroid hormone axis in children and adolescents: The Fukushima Health Management Survey.
    Thyroid. 2022 Sep 6. doi: 10.1089/thy.2022.0327.
    PubMed         Abstract available

  47. KUCHARECZKO A, Kopczynski J, Kowalik A, Hincza-Nowak K, et al
    A significance of concomitant BRAFV600E and TERT mutations in Polish patients with papillary thyroid microcarcinoma - a retrospective cohort study based on 430 cases.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0155.
    PubMed         Abstract available

  48. FINKELSTEIN S, Sistrunk J, Malchoff C, Thompson DV, et al
    A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise microRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules.
    Thyroid. 2022 Aug 9. doi: 10.1089/thy.2022.0124.
    PubMed         Abstract available

  49. TANEJA C, Yip L, Morariu EM, Seethala R, et al
    Clinicopathologic Characteristics and Postsurgical Follow-Up of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in the Postnomenclature Revision Era.
    Thyroid. 2022;32:1346-1352.
    PubMed         Abstract available

  50. CORSELLO A, Ramunno V, Locantore P, Pacini G, et al
    Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature.
    Thyroid. 2022 Jul 12. doi: 10.1089/thy.2021.0696.
    PubMed         Abstract available

  51. THIESMEYER JW, Egan C, Greenberg JA, Beninato T, et al
    Prepubertal Children with Papillary Thyroid Carcinoma Present with More Invasive Disease than Adolescents and Young Adults.
    Thyroid. 2022 Nov 10. doi: 10.1089/thy.2022.0098.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.